ImmuCell to Announce 2014 Full Year and Fourth Quarter Financial Results
Conference Call Scheduled for Wednesday, February 11, 2015 at 4:30 PM EST
(firmenpresse) - PORTLAND, ME -- (Marketwired) -- 02/04/15 -- (NASDAQ: ICCC) a growing animal health company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries, will report 2014 full year and fourth quarter financial results after the market closes on Wednesday, February 11, 2015. The Company has scheduled a conference call that same day Wednesday, February 11, 2015, at 4:30 PM EST to review the results.
Interested parties can access the conference call by dialing (866) 652-5200 or (412) 317-6060. A teleconference replay of the call will be available for three days at (877) 344-7529 or (412) 317-0088, confirmation # 10060351.
ImmuCell Corporation''s (NASDAQ: ICCC) purpose is to create scientifically-proven and practical products that improve animal health and productivity in the dairy and beef industries. ImmuCell has developed products that provide significant, immediate immunity to newborn dairy and beef livestock. The Company has also developed products that address mastitis, the most significant cause of economic loss to the dairy industry. Press releases and other information about the Company are available at our website, ().
Michael F. Brigham
President and CEO
ImmuCell Corporation
(207) 878-2770
Joe Diaz, Robert Blum and Joe Dorame
Lytham Partners, LLC
(602) 889-9700
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 04.02.2015 - 07:00 Uhr
Sprache: Deutsch
News-ID 1334759
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
PORTLAND, ME
Phone:
Kategorie:
Biotech
Anmerkungen:
Diese Pressemitteilung wurde bisher 92 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"ImmuCell to Announce 2014 Full Year and Fourth Quarter Financial Results
"
steht unter der journalistisch-redaktionellen Verantwortung von
ImmuCell Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
